US Bancorp
DMK

US Bancorp’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

US Bancorp’s Portfolio DMK Stock Details DMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-2
Closed – – 3659
2016
Q4 		$0 Sell
2
-121
-98% -$24.3K ﹤0.01% 3662
2016
Q3 		$30K Buy
123
+3
+3% +$623 ﹤0.01% 2679
2016
Q2 		$23K Sell
120
-128
-52% -$59K ﹤0.01% 2749
2016
Q1 		$107K Hold
248
– – ﹤0.01% 1975
2015
Q4 		$94K Hold
248
– – ﹤0.01% 2104
2015
Q3 		$67K Hold
248
– – ﹤0.01% 2308
2015
Q2 		$73K Sell
248
-8
-3% -$2.42K ﹤0.01% 2327
2015
Q1 		$71K Buy
256
+182
+246% +$78.6K ﹤0.01% 2374
2014
Q4 		$32K Buy
+74
New +$23.5K ﹤0.01% 2730

Other funds holding DMK

SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Axiom Investors Greenwich, Connecticut $8.99B AUM 44.68% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
LCM
Leisure Capital Management Costa Mesa, California $286M AUM 26.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

US Bancorp's DMK Position: Q1 2017 in Review

US Bancorp sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q1 2017, closing a stake of 2 shares.

US Bancorp first reported a position in DMK in Q4 2014 and held it in 9 quarters. The position peaked at $107K in Q1 2016. 30 funds tracked by Wall St. Rank hold DMK as of Q1 2017.

  • US Bancorp reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q1 2017 after selling out during the quarter.
  • US Bancorp sold 2 DMK Pharmaceuticals Corporation Common Stock shares in Q1 2017.
  • US Bancorp first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q4 2014 and held it in 9 quarters.
  • US Bancorp's DMK Pharmaceuticals Corporation Common Stock position peaked at $107K in Q1 2016.
  • 30 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q1 2017.

Based on US Bancorp's 13F filing for Q1 2017, filed 3 May 2017.